Effects of Ditropan (Oxybutynin) on Blood Pressure

Mechanism of Action and BP Effects

The American Urological Association notes that oxybutynin can cause both orthostatic hypotension and, less commonly, hypertension due to its anticholinergic properties 1, 2
As an anticholinergic medication, oxybutynin can cause orthostatic hypotension through parasympathetic inhibition, particularly when initiating therapy 1, 2

Elderly patients are more susceptible to blood pressure fluctuations with anticholinergic medications like oxybutynin 2
Patients with higher baseline blood pressure may experience greater increases when taking oxybutynin 2
Concomitant use of other medications with cardiovascular effects can potentiate BP changes 3

Orthostatic hypotension is more common than hypertension with oxybutynin, particularly in elderly patients and those taking other medications that may cause orthostatic effects 1, 2, 3
Blood pressure monitoring is recommended at baseline before starting therapy, during dose adjustments, and periodically during maintenance therapy 1, 4, 5

For patients experiencing orthostatic hypotension, consider dose reduction, advise patients to change positions slowly, and ensure adequate hydration 1, 3
For patients experiencing hypertension, RAS-inhibitors and diuretics are preferred due to fewer pharmacological interactions with anticholinergic medications 2

Monitor for signs of orthostatic hypotension and check blood pressure in both seated and standing positions when initiating therapy 1, 4
Consider more frequent monitoring in patients with pre-existing cardiovascular disease or hypertension 5

Anticholinergic medications like oxybutynin are considered "strongly anticholinergic" and are often poorly tolerated in elderly patients due to their broad muscarinic receptor blockade, according to the Mayo Clinic Proceedings 6
The "anticholinergic burden" from taking multiple anticholinergic drugs can adversely affect cognition and functionality, and may exacerbate cardiovascular effects, as reported by the Mayo Clinic Proceedings 6
The Drug Burden Index shows that drugs with strong anticholinergic properties, like oxybutynin, are associated with decline in cognition, functional status, and activities of daily living scores in older patients, as noted by the Mayo Clinic Proceedings 6

If blood pressure changes are significant, consider alternative medications for overactive bladder with fewer anticholinergic effects, as suggested by the Mayo Clinic Proceedings 6
In patients with spina bifida requiring anticholinergic therapy, regular blood pressure monitoring is essential, according to The Journal of Urology 7
Oxybutynin is listed among medications that should be considered for deprescribing in older adults due to its strong anticholinergic effects and potential for adverse events, as recommended by the Mayo Clinic Proceedings 6
When deprescribing antihypertensives, careful monitoring is needed, especially in patients also taking medications like oxybutynin that may affect blood pressure, as advised by the Mayo Clinic Proceedings 6